Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
4.180
-0.010 (-0.24%)
At close: Feb 4, 2026, 4:00 PM EST
4.240
+0.060 (1.44%)
After-hours: Feb 4, 2026, 6:14 PM EST
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $12.87 million as of February 4, 2026. Its market cap has increased by 129.84% in one year.
Market Cap
12.87M
Enterprise Value
6.59M
1-Year Change
129.84%
Ranking
Category
Stock Price
$4.18
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $12.87M, a decrease of -81.79%. That is a compound annual growth rate of -16.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 8.50M | 26.87% |
| Dec 31, 2025 | 6.70M | 31.37% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
| Jun 2, 2016 | 70.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kairos Pharma | 13.83M |
| Hoth Therapeutics | 13.78M |
| Cellectar Biosciences | 13.65M |
| Cocrystal Pharma | 13.51M |
| Tempest Therapeutics | 13.40M |
| BioCardia | 13.05M |
| CalciMedica | 12.97M |
| BioLineRx | 12.64M |